You are here: Home » PTI Stories » National » News
Business Standard

Medicines worth Rs 32 cr supplied to Kashmir between July 20 and August 23: Administration

Health Medical Pharma

Press Trust of India  |  Srinagar 

The Jammu and Kashmir administration on Monday termed "baseless" rumours and reports suggesting shortage of medicines in Kashmir markets and said drugs worth around Rs 32 crore have been supplied to the valley from July 20 to August 23.

The medicines include a wide range of drugs from all categories, including antibiotics, anti-diabetic, proton pump inhibitors, anti-hypertensives, antacids, NSAIDs, anti-cancer drugs, cardiovascular drugs, anti-tuberculars, anti-depressants, psychotropics, an official spokesman said.

Teams of drug control officers were deputed to depots, C&Fs and consignees of major pharmaceutical companies to collect relevant data regarding supplies of medicines and pharmaceutical drug formulations made to pharma dealers and distributors across the valley in the last one month, he said.

As per drug controller, special efforts are being made to ensure and facilitate timely supply of medicines which require specialised storage conditions to authorised stockists and stake holders in Kashmir.

A number of stockists and distributors based in Kashmir procure different categories of medicines as per their needs and requirements directly from manufacturers, super-stockists and distributors based outside J&K, he said. The figure given above excludes that, he said.

Moreover, the field functionaries of drugs control organisation Kashmir and the project coordinator, Pradhan Mantri Bhartiya Jan Aushadi Yojana, have informed that all outlets of the Pradhan Mantri Jan Aushadi are fully operational at different locations in Srinagar and have sufficient stocks of all categories of drugs.

In addition to this, there are around 40 outlets operational under the PMJAY scheme in the Kashmir division catering to those in need, he said.

The department said that it is in constant touch with heads of all health institutions of the valley to assess their availability and requirement of medicines. It said any instances of unavailability of medicines are dealt with on priority.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, August 26 2019. 22:05 IST